>

Regeneron Stock Price Prediction

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:4em;padding-top: 25px;;'>RE</div>
REGN -- USA Stock  

Upward Rally

Regeneron Pharmaceuticals Accrued Expenses Turnover is quite stable at the moment as compared to the last year. The company current value of Accrued Expenses Turnover is estimated at about 11.33. Operating Margin is projected to rize to 32.16 this year, although the value of Interest Coverage will most likelly fall to 68.39. We analyze noise-free headlines and recent hype associated with Regeneron Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Using Regeneron Pharmaceuticals hype-based prediction, you can estimate the value of Regeneron Pharmaceuticals from the perspective of Regeneron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. The Regeneron stock price prediction module also provides an analysis of price elasticity to changes in media outlook on Regeneron Pharmaceuticals over a specific investment horizon. Additionally, take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Equity
Refresh

Regeneron Pharmaceuticals After-Hype Price Density Analysis

 Next price density 
    
  Expected price to next headline 

Regeneron Pharmaceuticals Estimiated After-Hype Price Volatility

Current Value
452.66
February 25, 2020
421.06
Downside
426.55
After-hype Price
432.04
Upside
Regeneron Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Regeneron Pharmaceuticals is based on 3 months time horizon.

Regeneron Pharmaceuticals Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.34  1.98  1.47   0.28  7 Events / Month3 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
452.66426.550.28 
45.83  

Regeneron Pharmaceuticals Hype Timeline

Regeneron Pharmaceuticals is at this time traded for452.66. The entity has historical hype elasticity of 1.47 and average elasticity to hype of competition of 0.28. Regeneron Pharmaceuticals is projected to increase in value after the next headline with price going to jump to 426.55. The average volatility of media hype impact on the company stock price is about 45.83%. The price appreciation on the next news is anticipated to be 0.28% where as daily expected return is at this time at 0.34%. The volatility of related hype on Regeneron Pharmaceuticals is about 241.76% with expected price after next announcement by competition of 452.94. The company reported previous year revenue of 7.62 B. Net Income was 2.14 B with profit before overhead, payroll, taxes, and interest of 4.09 B. Given the investment horizon of 30 days, the next projected press release will be in about 7 days.
Additionally, take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Regeneron Pharmaceuticals Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Vertex Pharmaceuticals Incorpor 2.81 8 per month 1.05  0.12  2.42 (1.89)  6.23 
Dr Reddys Laboratories Ltd 0.27 9 per month 1.46  0.1  2.88 (2.54)  8.79 
Sinovac Biotech Ltd 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Zoetis 0.39 9 per month 0.83  0.19  1.69 (1.55)  5.83 
Immune Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Perrigo Company Plc 0.34 11 per month 0.96  0.15  2.22 (1.91)  15.60 
PAREXEL International Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Regeneron Pharmaceuticals 4.32 7 per month 1.31  0.18  4.36 (1.84)  8.58 
SciClone Pharmaceuticals, In 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Origin Agritech Limited 0.06 2 per month 4.04  0.07  4.77 (7.36)  58.70 

Contributor Headline

Latest Perspective on Regeneron Pharmaceuticals

Additionally, take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Company logos by clearbit